Literature DB >> 25328122

Elevated expression of long intergenic non-coding RNA HOTAIR in a basal-like variant of MCF-7 breast cancer cells.

Yan Zhuang1, Hong T Nguyen1, Matthew E Burow1, Ying Zhuo2, Samir S El-Dahr3, Xiao Yao2, Subing Cao4, Erik K Flemington4, Kenneth P Nephew5, Fang Fang5, Bridgette Collins-Burow1, Lyndsay V Rhodes1, Qiang Yu6, Janarthanan Jayawickramarajah7, Bin Shan8.   

Abstract

Epigenetic regulation of gene expression is critical to phenotypic maintenance and transition of human breast cancer cells. HOX antisense intergenic RNA (HOTAIR) is a long intergenic non-coding RNA that epigenetically represses gene expression via recruitment of enhancer of zeste homolog 2 (EZH2), a histone methyltransferase. Elevated expression of HOTAIR promotes progression of breast cancer. In the current study we examined the expression and function of HOTAIR in MCF-7-TNR cells, a derivative of the luminal-like breast cancer cell line MCF-7 that acquired resistance to TNF-α-induced cell death. The expression of HOTAIR, markers of the luminal-like and basal-like subtypes, and growth were compared between MCF-7 and MCF-7-TNR cells. These variables were further assessed upon inhibition of HOTAIR, EZH2, p38 MAPK, and SRC kinase in MCF-7-TNR cells. When compared with MCF-7 cells, MCF-7-TNR cells exhibited an increase in the expression of HOTAIR, which correlated with characteristics of a luminal-like to basal-like transition as evidenced by dysregulated gene expression and accelerated growth. MCF-7-TNR cells exhibited reduced suppressive histone H3 lysine27 trimethylation on the HOTAIR promoter. Inhibition of HOTAIR and EZH2 attenuated the luminal-like to basal-like transition in terms of gene expression and growth in MCF-7-TNR cells. Inhibition of p38 and SRC diminished HOTAIR expression and the basal-like phenotype in MCF-7-TNR cells. HOTAIR was robustly expressed in the native basal-like breast cancer cells and inhibition of HOTAIR reduced the basal-like gene expression and growth. Our findings suggest HOTAIR-mediated regulation of gene expression and growth associated with the basal-like phenotype of breast cancer cells.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  EZH2; HOTAIR; breast cancer; lincRNA

Mesh:

Substances:

Year:  2014        PMID: 25328122      PMCID: PMC4402121          DOI: 10.1002/mc.22237

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  65 in total

1.  Interaction of developmental transcription factor HOXC11 with steroid receptor coactivator SRC-1 mediates resistance to endocrine therapy in breast cancer [corrected].

Authors:  Marie McIlroy; Damian McCartan; Sarah Early; Peadar O Gaora; Stephen Pennington; Arnold D K Hill; Leonie S Young
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

2.  Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor alpha by phosphorylation.

Authors:  T Rogalla; M Ehrnsperger; X Preville; A Kotlyarov; G Lutsch; C Ducasse; C Paul; M Wieske; A P Arrigo; J Buchner; M Gaestel
Journal:  J Biol Chem       Date:  1999-07-02       Impact factor: 5.157

3.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

4.  Pharmacological inhibition of HDAC6 attenuates endothelial barrier dysfunction induced by thrombin.

Authors:  Shigeki Saito; Joseph A Lasky; Weichao Guo; Hong Nguyen; Antonello Mai; Svitlana Danchuk; Deborah E Sullivan; Bin Shan
Journal:  Biochem Biophys Res Commun       Date:  2011-04-21       Impact factor: 3.575

5.  High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer.

Authors:  A T Ferguson; E Evron; C B Umbricht; T K Pandita; T A Chan; H Hermeking; J R Marks; A R Lambers; P A Futreal; M R Stampfer; S Sukumar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

6.  TNF-stimulated MAP kinase activation mediated by a Rho family GTPase signaling pathway.

Authors:  Shashi Kant; Wojciech Swat; Sheng Zhang; Zhong-Yin Zhang; Benjamin G Neel; Richard A Flavell; Roger J Davis
Journal:  Genes Dev       Date:  2011-10-01       Impact factor: 11.361

7.  Pharmacology and anti-tumor activity of RWJ67657, a novel inhibitor of p38 mitogen activated protein kinase.

Authors:  James W Antoon; Melyssa R Bratton; Lori M Guillot; Scott Wadsworth; Virgilio A Salvo; Steven Elliott; John A McLachlan; Matthew E Burow
Journal:  Am J Cancer Res       Date:  2012-06-28       Impact factor: 6.166

8.  Identification of mitogen-activated protein kinase kinase as a chemoresistant pathway in MCF-7 cells by using gene expression microarray.

Authors:  Christopher B Weldon; Ali B Scandurro; Kevin W Rolfe; John L Clayton; Steven Elliott; Nancy N Butler; Lilia I Melnik; Jawed Alam; John A McLachlan; Bernard M Jaffe; Barbara S Beckman; Matthew E Burow
Journal:  Surgery       Date:  2002-08       Impact factor: 3.982

9.  Epigenetic regulation of cell type-specific expression patterns in the human mammary epithelium.

Authors:  Reo Maruyama; Sibgat Choudhury; Adam Kowalczyk; Marina Bessarabova; Bryan Beresford-Smith; Thomas Conway; Antony Kaspi; Zhenhua Wu; Tatiana Nikolskaya; Vanessa F Merino; Pang-Kuo Lo; X Shirley Liu; Yuri Nikolsky; Saraswati Sukumar; Izhak Haviv; Kornelia Polyak
Journal:  PLoS Genet       Date:  2011-04-21       Impact factor: 5.917

10.  Altered death receptor signaling promotes epithelial-to-mesenchymal transition and acquired chemoresistance.

Authors:  James W Antoon; Rongye Lai; Amanda P Struckhoff; Ashley M Nitschke; Steven Elliott; Elizabeth C Martin; Lyndsay V Rhodes; Nam Seung Yoon; Virgilio A Salvo; Bin Shan; Barbara S Beckman; Kenneth P Nephew; Matthew E Burow
Journal:  Sci Rep       Date:  2012-07-27       Impact factor: 4.379

View more
  19 in total

Review 1.  Long Non-coding RNA HOTAIR in Central Nervous System Disorders: New Insights in Pathogenesis, Diagnosis, and Therapeutic Potential.

Authors:  Jialu Wang; Jiuhan Zhao; Pan Hu; Lianbo Gao; Shen Tian; Zhenwei He
Journal:  Front Mol Neurosci       Date:  2022-06-23       Impact factor: 6.261

Review 2.  Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic Implications.

Authors:  Wei Wang; Jiang-Jiang Qin; Sukesh Voruganti; Subhasree Nag; Jianwei Zhou; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2015-07-30       Impact factor: 12.944

Review 3.  Role of long non-coding RNA in tumor drug resistance.

Authors:  Heng Deng; Jun Zhang; JinJun Shi; ZhengDong Guo; ChunRong He; Li Ding; Jin Hai Tang; Yong Hou
Journal:  Tumour Biol       Date:  2016-07-05

Review 4.  EZH2 in Bladder Cancer, a Promising Therapeutic Target.

Authors:  Mónica Martínez-Fernández; Carolina Rubio; Cristina Segovia; Fernando F López-Calderón; Marta Dueñas; Jesús M Paramio
Journal:  Int J Mol Sci       Date:  2015-11-13       Impact factor: 5.923

5.  Genetic variants of lncRNA HOTAIR and risk of epithelial ovarian cancer among Chinese women.

Authors:  Haijing Wu; Xiaofei Shang; Yu Shi; Zhirong Yang; Jun Zhao; Min Yang; Yan Li; Shiqiang Xu
Journal:  Oncotarget       Date:  2016-07-05

6.  Induction of a novel isoform of the lncRNA HOTAIR in Claudin-low breast cancer cells attached to extracellular matrix.

Authors:  Miao Li; Xi Li; Yan Zhuang; Erik K Flemington; Zhen Lin; Bin Shan
Journal:  Mol Oncol       Date:  2017-10-30       Impact factor: 6.603

7.  Polymorphisms of long non-coding RNA HOTAIR with breast cancer susceptibility and clinical outcomes for a southeast Chinese Han population.

Authors:  Yuxiang Lin; Wenhui Guo; Neng Li; Fangmeng Fu; Songping Lin; Chuan Wang
Journal:  Oncotarget       Date:  2017-12-16

Review 8.  Current Knowledge of Long Non-Coding RNA HOTAIR in Breast Cancer Progression and Its Application.

Authors:  Yubo Shi; Qingyun Huang; Xinyu Kong; Ruichen Zhao; Xinyue Chen; Yujia Zhai; Lixia Xiong
Journal:  Life (Basel)       Date:  2021-05-26

Review 9.  Functions of lncRNA HOTAIR in lung cancer.

Authors:  Gregory Loewen; Janarthanan Jayawickramarajah; Ying Zhuo; Bin Shan
Journal:  J Hematol Oncol       Date:  2014-12-10       Impact factor: 17.388

10.  Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer.

Authors:  Michael J G Milevskiy; Fares Al-Ejeh; Jodi M Saunus; Korinne S Northwood; Peter J Bailey; Joshua A Betts; Amy E McCart Reed; Kenneth P Nephew; Andrew Stone; Julia M W Gee; Dennis H Dowhan; Eloise Dray; Annette M Shewan; Juliet D French; Stacey L Edwards; Susan J Clark; Sunil R Lakhani; Melissa A Brown
Journal:  Hum Mol Genet       Date:  2016-07-04       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.